Loading
Molina Healthcare, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 12 Feb 2026.
Molina Healthcare, Inc.: what insiders have been doing
Headquartered in Long Beach, United States, Molina Healthcare, Inc. belongs to the Healthcare & Pharma sector and traces its origins to 1980. Filings by its managers are published through SEC (Form 4). Between 18 October 2025 and 18 October 2026, 15 insiders published 40 filings.
On the market, 1 insider bought (1 purchase totalling €84k) while 3 insiders sold (3 sales totalling €207k). On balance, insiders were net sellers of €123k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Among those who bought: 1 senior executive. Biggest ticket of the year: €99k, sold by Hebert Maurice and made public on 15 May 2026 (0.0011% of market cap).
The latest purchase dates back some time: it was published 248 days ago, on 12 February 2026. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Across the 5,458 companies tracked on its exchange, the median is 22 filings; at 40 filings, this issuer sits above that mark. Since 2016, the database holds 2 purchases and 53 sales by insiders of the company. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 45.43 bn USD and net income of 472.0 m USD.
In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
311
Thresholds
n/a
Buy Volume
€822,937
2 ops. · all time
Sell Volume
€56M
53 ops. · all time
Who traded when
BuySaleRichard M. Schapiro3 sales
Ronna Romney2 sales
Steven J. Orlando2 sales
Dale B. Wolf1 sale
James Woys1 buy
Joseph M. Zubretsky1 sale
+2 other insiders
Since the insiders bought
- +38.0%Entry US$135.35 · Close at T+90 US$186.80
- +26.7%Entry US$155.00 · Close at T+365 US$196.45
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Molina Healthcare, Inc. Hold (neutral), based on 17 analysts. Average price target: US$209.12.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 19,318 of 24,148 companies
30.9
score / 100
Value39
Quality23
FCF yld-5.9%
Earn yld4.4%
EV/EBITDA15.1x
ROE-0.2%
Gross mgn9.0%
Net mgn1.0%
Debt/EBITDA4.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$207.36
Analyst consensus
17 analystsHold
US$147.00Target US$209.12(+1%)US$266.00
Income statement
RevenueUS$45.4B
Gross profitUS$4.1B9% margin
EBITDAUS$976M2% margin
Net incomeUS$472M-0.0% margin
Valuation
PER (trailing)2304.0x
PER (forward)21.3x
P/Book2.6x
Beta0.78
Balance sheet & cash
Market capUS$10.8B
Total debtUS$4B
Free Cash Flow-US$636M
Debt / Equity95%
Profitability & ownership
ROE-0.2%
ROA1.2%
% insiders1.4%
% institutions112.0%
Last declaration on 2 October 2026
Declarations311 total
304 shares@ US$180.850.0006% mcap4.3% of flowCommon StockSEC:0001263714-26-000011:0
304 shares@ US$180.850.0006% mcap2.0% of flowCommon StockSEC:0001228861-26-000010:0
304 shares@ US$180.850.0006% mcap1.8% of flowCommon StockSEC:0001649773-26-000008:0
304 shares@ US$180.850.0006% mcap2.2% of flowCommon StockSEC:0001206684-26-000010:0
304 shares@ US$180.850.0006% mcap1.5% of flowCommon StockSEC:0001211493-26-000008:0
304 shares@ US$180.850.0006% mcap4.6% of flowCommon StockSEC:0001856013-26-000008:0
304 shares@ US$180.850.0006% mcap18.0% of flowCommon StockSEC:0001257996-26-000008:0
304 shares@ US$180.850.0006% mcap100.0% of flowCommon StockSEC:0001233184-26-000017:0
304 shares@ US$180.850.0006% mcap3.3% of flowCommon StockSEC:0001169490-26-000008:0
237 sharesCommon StockSEC:0001169490-26-000006:0
23 sharesCommon StockSEC:0002010075-26-000006:0
183 sharesCommon StockSEC:0002010075-26-000006:1
138 sharesCommon StockSEC:0001555603-26-000006:0
600 shares@ US$191.550.0011% mcap4.6% of flowCommon StockSEC:0001267043-26-000004:0
405 shares@ US$135.822.2% of flowCommon StockSEC:0001206684-26-000006:0
405 shares@ US$135.821.4% of flowCommon StockSEC:0001211493-26-000004:0
405 shares@ US$135.822.0% of flowCommon StockSEC:0001228861-26-000004:0
405 shares@ US$135.824.4% of flowCommon StockSEC:0001263714-26-000006:0
405 shares@ US$135.821.8% of flowCommon StockSEC:0001649773-26-000004:0
405 shares@ US$135.823.4% of flowCommon StockSEC:0001169490-26-000004:0
405 shares@ US$135.8221.5% of flowCommon StockSEC:0001257996-26-000004:0
405 shares@ US$135.824.7% of flowCommon StockSEC:0001856013-26-000004:0
506 shares@ US$146.923.0% of flowCommon StockSEC:0001206684-26-000004:0
716 shares@ US$154.053.1% of flowCommon StockSEC:0002010075-26-000004:0
650 shares@ US$154.054.0% of flowCommon StockSEC:0001267043-26-000002:0
25 of 311 declarations
About Molina Healthcare, Inc.
Molina Healthcare, Inc. (NYSE: MOH) is a leading U.S. managed care company focused on government-sponsored healthcare programs and lower-income populations. The company was founded in 1980 as a provider organization serving low-income families in Southern California and was later reincorporated in Delaware in 2002. Its headquarters are in Long Beach, California, United States. For investors, Molina sits squarely in the U.S. listed healthcare universe, with a business model that is defensive in nature but highly sensitive to reimbursement trends, state contracts, and regulatory execution. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1179929/000117992925000023/moh-20241231.htm?utm_source=openai))
Molina’s operating model is centered on three main business lines: Medicaid, Medicare, and Marketplace. Medicaid remains the core engine, where the company manages health plans for state-sponsored beneficiaries under long-term contracts with U.S. states. Its Medicare operations target seniors, including dual-eligible populations and other managed-care segments, while Marketplace provides individual exchange-based coverage. This mix makes Molina a specialized public-program managed care platform rather than a broad consumer brand; execution, medical-cost control, and contract performance are the key drivers of results. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1179929/000117992925000023/moh-20241231.htm?utm_source=openai))
Read moreShow less
From a competitive standpoint, Molina is differentiated by its depth in Medicaid managed care, a market where state relationships, pricing discipline, and operational consistency matter more than name recognition. The company has continued to widen its footprint through contract wins and targeted acquisitions, which have supported premium revenue growth and expanded its geographic scale. Recent company disclosures highlighted new and expanded business across multiple states, alongside acquisition-related contributions to growth. ([investors.molinahealthcare.com](https://investors.molinahealthcare.com/news-releases/news-release-details/molina-healthcare-reports-second-quarter-2025-financial-results?utm_source=openai))
Geographically, Molina operates across a broad multi-state U.S. footprint, with historical roots in California and an expanded presence in other states through Medicaid, Medicare, and Marketplace programs. Recent results show that the company remained in growth mode in 2025, with full-year premium revenue of about $43.1 billion and 2026 guidance near $42 billion, reflecting the combined effect of acquisitions, rate increases, and organic growth. Management also flagged elevated medical-cost pressure and announced a planned exit from the traditional Medicare Advantage Part D product for 2027, which is an important strategic and margin consideration for medium-term investors. ([investors.molinahealthcare.com](https://investors.molinahealthcare.com/news-releases/news-release-details/molina-healthcare-reports-fourth-quarter-and-year-end-2025?utm_source=openai))
In summary, Molina Healthcare is a high-quality U.S. managed care franchise listed on the NYSE and headquartered in the United States, with a strong Medicaid-led model, disciplined operating profile, and a growth strategy based on public-program contracts. Recent developments suggest continued expansion, but also highlight the sector’s exposure to reimbursement cycles, utilization pressure, and policy-driven changes. ([investors.molinahealthcare.com](https://investors.molinahealthcare.com/news-releases/news-release-details/molina-healthcare-reports-fourth-quarter-and-year-end-2025?utm_source=openai))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
